Grafa

Grafa generates AI-driven data, news and analysis about NYSE, Nasdaq and ASX stocks

    • GrafaGrafa
      ·08-18 15:17

      Uber targets 1 million daily Zipline deliveries

      Full story: https://grafa.com/en/news/united-states/uber-zipline-one-million-daily-drone-deliveries-2029 Uber and Zipline partnered to bring autonomous drone delivery to Uber Eats customers across the U.S., with first deliveries planned later in 2026. Uber shares were up 0.7% at $76.47 in Monday trading following the announcement. The companies said they aim to scale the service to one million drone deliveries per day by the end of 2029. Uber Technologies (NYSE:UBER) partnered with Zipline to launch autonomous Uber Eats drone deliveries in the U.S., targeting one million daily deliveries by the end of 2029. The agreement follows Uber’s 2025 partnership and investment in drone operator Flytrex, while financial terms of its new Zipline investment were not disclosed. The service will begin in
      1Comment
      Report
      Uber targets 1 million daily Zipline deliveries
    • GrafaGrafa
      ·08-18 15:16

      EyePoint LUGANO misses endpoint despite 42% reduction

      Full story: https://grafa.com/en/news/united-states/eyepoint-lugano-phase-3-duravyu-primary-endpoint EyePoint said DURAVYU did not meet LUGANO’s primary BCVA endpoint in the full dataset, although an ad hoc analysis showed non-inferiority. EyePoint shares were down about 70% at $4.43 in early Nasdaq trading following the results. DURAVYU reduced treatment burden by 42%, while EyePoint expects the second Phase 3 LUCIA readout in Q4 2026. EyePoint (NASDAQ:EYPT) said DURAVYU 2.7mg missed LUGANO’s primary BCVA endpoint against 2mg aflibercept in the full Phase 3 dataset. An ad hoc analysis excluding nine of 211 DURAVYU patients with unrelated vision loss showed non-inferiority to aflibercept at nominal p=0.0096. DURAVYU reduced treatment burden 42%, while 54% remained supplement-free and 79% r
      49Comment
      Report
      EyePoint LUGANO misses endpoint despite 42% reduction
    • GrafaGrafa
      ·08-18 15:15

      BitFuFu Q2 revenue falls 63% to $42.8 million

      Full story: https://grafa.com/en/news/united-states/bitfufu-q2-2026-revenue-42-8-million-net-loss BitFuFu reported Q2 2026 revenue of $42.8 million, down 62.9% from $115.4 million a year earlier. BitFuFu shares were up 11.3% at $1.45 in pre-market trading following the earnings release. The company said managed hashrate had recovered to approximately 20 EH/s by mid-August after falling to 15.3 EH/s at June 30. BitFuFu (NASDAQ:FUFU) reported Q2 2026 revenue of $42.8 million, down 62.9%, while net income swung to a $20.5 million loss. Cloud Mining Solutions revenue fell 73.6% to $24.9 million, while self-mining generated $14 million and Hosting and Other revenue increased to $3.9 million. Adjusted EBITDA was negative $18.4 million as a $16.9 million digital-asset fair value loss replaced a $
      0Comment
      Report
      BitFuFu Q2 revenue falls 63% to $42.8 million
    • GrafaGrafa
      ·08-18 15:14

      Freightos Q2 revenue reaches record $7.7 million

      Full story: https://grafa.com/en/news/united-states/freightos-q2-2026-record-7-7-million-revenue Freightos reported record Q2 2026 revenue of $7.7 million, up 3%, while its IFRS net loss narrowed to $1.6 million. Freightos shares were up 2.3% at $1.35 in pre-market trading following the results. Freightos expects full-year revenue of $30.4–$31 million and an adjusted EBITDA loss of $6.4–$6.9 million. Freightos (NASDAQ:CRGO) reported record Q2 2026 revenue of $7.7 million, up 3%, while adjusted EBITDA loss improved to $2 million. The platform processed a record $422 million of GBV across 458,000 transactions, representing year-over-year increases of 33% and 15%, respectively. Platform revenue rose 19% to $2.9 million, Solutions revenue fell 4% to $4.8 million, and Freightos ended June with
      1Comment
      Report
      Freightos Q2 revenue reaches record $7.7 million
    • GrafaGrafa
      ·08-18 15:13

      AstraZeneca ENHERTU improves PFS in Phase III

      Full story: https://grafa.com/en/news/united-states/astrazeneca-enhertu-destiny-lung04-phase-3-pfs-results AstraZeneca and Daiichi Sankyo said ENHERTU significantly improved progression-free survival versus standard first-line therapy in the Phase III DESTINY-Lung04 trial. AstraZeneca ADRs were down 0.5% at $156.45 in pre-market trading amid several same-day lung cancer pipeline updates. The companies plan to present detailed results at a medical meeting and share the data with global regulators while overall survival continues to be assessed. AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said ENHERTU significantly improved progression-free survival versus standard first-line treatment in the Phase III DESTINY-Lung04 lung cancer trial. The trial compared ENHERTU with platinum-pemetrexed chem
      13Comment
      Report
      AstraZeneca ENHERTU improves PFS in Phase III
    • GrafaGrafa
      ·08-18 15:10

      Madison Air agrees $5.4 billion ebm-papst deal

      Full story: https://grafa.com/en/news/united-states/madison-air-5-4-billion-ebm-papst-acquisition Madison Air agreed to acquire ebm-papst for a $5.4 billion enterprise value, or an effective $5 billion after expected tax savings. Madison Air shares were down 1.2% at $31.28 in pre-market trading following the announcement. Madison Air expects $160 million of annual run-rate cost synergies by year three and adjusted EPS accretion in the first full year after closing. Madison Air Solutions (NYSE:MAIR) agreed to acquire German airflow technology provider ebm-papst for a $5.4 billion enterprise value, or an effective $5 billion purchase price after expected tax savings. ebm-papst operates across roughly 40 countries and is forecast by Madison Air to generate about $2.8 billion of 2026 revenue a
      0Comment
      Report
      Madison Air agrees $5.4 billion ebm-papst deal
    • GrafaGrafa
      ·08-18 14:57

      TTM agrees $1.1 billion Epiq acquisition

      Full story: https://grafa.com/en/news/united-states/ttm-technologies-1-1-billion-epiq-design-solutions-acquisition TTM agreed to acquire Epiq Design Solutions for approximately $1.1 billion in cash, subject to customary closing adjustments. TTM shares were up about 0.9% at $140 in pre-market trading following the announcement. TTM expects the acquisition to immediately increase Adjusted EBITDA margin and become accretive to non-GAAP diluted EPS during 2028. TTM Technologies (NASDAQ:TTMI) agreed to acquire Epiq Design Solutions for approximately $1.1 billion in cash to expand its integrated electronics portfolio. TTM said Epiq adds software-defined radios, RF products and space computing technology for defense applications, including missile defense, electronic warfare and ISR. TTM cited a
      7Comment
      Report
      TTM agrees $1.1 billion Epiq acquisition
    • GrafaGrafa
      ·08-18 14:56

      Genco defends $27.50 takeover terms after withdrawal

      Full story: https://grafa.com/en/news/united-states/genco-27-50-takeover-framework-diana-shipping-withdrawal Genco defended a takeover framework requiring $27.50 per share in cash, three Diana shares per Genco share and retained dividends. GNK was down 3.6% at $25.39 in pre-market trading, while the  stock was also trading ex-dividend for its $0.80 payout. Genco said it projects cumulative Q3 and Q4 2026 dividends of more than $2 per share, subject to market assumptions. Genco Shipping & Trading (NYSE:GNK) defended its $27.50-per-share cash framework after Diana Shipping (NYSE:DSX) withdrew its offer to acquire the remaining Genco shares. Diana said Genco's requested terms implied about $36.91 per share, while Genco disputed that calculation and estimated its NAV at approximately
      0Comment
      Report
      Genco defends $27.50 takeover terms after withdrawal
    • GrafaGrafa
      ·08-18 14:54

      Lifeward Q2 revenue skyrockets 16% to $6.6 million

      Full story: https://grafa.com/en/news/united-states/lifeward-q2-2026-revenue-6-6-million Lifeward reported Q2 2026 revenue of $6.62 million, up 16% year-over-year, while adjusted loss was $1.46 per share. Adjusted EPS beat the Zacks estimate by 2.01%, although revenue missed the consensus estimate by 10.74%. Lifeward ended June with $9.4 million in cash and said it expects revenue momentum to continue during the second half of 2026. Lifeward (NASDAQ:LFWD) reported Q2 2026 revenue of $6.62 million, up 16% year-over-year, while adjusted loss was $1.46 per share. The adjusted loss beat the Zacks consensus estimate of $1.49 by 2.01%, while revenue missed its consensus estimate by 10.74%. GAAP net loss was $11.5 million, gross margin fell to 41% from 44%, and unrestricted cash reached $9.4 mill
      13Comment
      Report
      Lifeward Q2 revenue skyrockets 16% to $6.6 million
    • GrafaGrafa
      ·08-18 14:53

      Duos delivers Q2 revenue of $6.18M, up 30%

      Full story: https://grafa.com/en/news/united-states/duos-technologies-q2-2026-revenue-6-18-million Duos Technologies reported Q2 2026 revenue of $6.18 million, up nearly 30%, and its first positive operating quarter as a data center infrastructure company. DUOT shares were 9.5% at $9.98 shortly before the release. Duos reaffirmed its 2026 targets of more than $50 million in revenue and deployment of 25 MW of contracted capacity. Duos Technologies Group (NASDAQ:DUOT) reported Q2 2026 revenue of $6.18 million, up 30% year-over-year, while operating income reached $0.05 million. Revenue included $3.23 million from Technology Solutions, $2.91 million from Services and Consulting and about $33,000 from Hosting, while gross margin increased to $3.45 million. Pre-tax income reached $53.64 million
      7Comment
      Report
      Duos delivers Q2 revenue of $6.18M, up 30%
     
     
     
     

    Most Discussed